159 related articles for article (PubMed ID: 21882004)
21. Artificial neural network-based diagnostic models for lung cancer combining conventional indicators with tumor markers.
Luo Y; Yuan H; Pei Q; Chen Y; Xian J; Du R; Ye T
Exp Biol Med (Maywood); 2023 May; 248(10):829-838. PubMed ID: 37403334
[TBL] [Abstract][Full Text] [Related]
22. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
Li X; Zhang Q; Jin X; Cao L
World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of chest radiography, computed tomography and tumour markers in the differentiation of malignant from benign solitary pulmonary lesions.
Seemann MD; Seemann O; Dienemann H; Schalhorn A; Prime G; Fink U
Eur J Med Res; 1999 Aug; 4(8):313-27. PubMed ID: 10471543
[TBL] [Abstract][Full Text] [Related]
24. Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer.
Zhang Z; Yu Y; Xu F; Berchuck A; van Haaften-Day C; Havrilesky LJ; de Bruijn HW; van der Zee AG; Woolas RP; Jacobs IJ; Skates S; Chan DW; Bast RC
Gynecol Oncol; 2007 Dec; 107(3):526-31. PubMed ID: 17920110
[TBL] [Abstract][Full Text] [Related]
25. An artificial neural network (ANN)-based lung-tumor motion predictor for intrafractional MR tumor tracking.
Yun J; Mackenzie M; Rathee S; Robinson D; Fallone BG
Med Phys; 2012 Jul; 39(7):4423-33. PubMed ID: 22830775
[TBL] [Abstract][Full Text] [Related]
26. An artificial neural network for predicting the incidence of radiation pneumonitis.
Su M; Miften M; Whiddon C; Sun X; Light K; Marks L
Med Phys; 2005 Feb; 32(2):318-25. PubMed ID: 15789575
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Diagnosis Accuracy between a Backpropagation Artificial Neural Network Model and Linear Regression in Digestive Disease Patients: an Empirical Research.
Wei W; Yang X
Comput Math Methods Med; 2021; 2021():6662779. PubMed ID: 33727951
[TBL] [Abstract][Full Text] [Related]
28. Computer-aided diagnostic scheme for distinction between benign and malignant nodules in thoracic low-dose CT by use of massive training artificial neural network.
Suzuki K; Li F; Sone S; Doi K
IEEE Trans Med Imaging; 2005 Sep; 24(9):1138-50. PubMed ID: 16156352
[TBL] [Abstract][Full Text] [Related]
29. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.
Wang B; He YJ; Tian YX; Yang RN; Zhu YR; Qiu H
Asian Pac J Cancer Prev; 2014; 15(22):9611-4. PubMed ID: 25520076
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic performance of a computer-assisted diagnostic system: sensitivity of BONENAVI for bone scintigraphy in patients with disseminated skeletal metastasis is not so high.
Koizumi M; Motegi K; Koyama M; Ishiyama M; Togawa T; Makino T; Arisaka Y; Terauchi T
Ann Nucl Med; 2020 Mar; 34(3):200-211. PubMed ID: 31970706
[TBL] [Abstract][Full Text] [Related]
31. Preliminary study on auxiliary value of serum basic fetoprotein in diagnosing lung cancer.
Mizushima Y; Tsuji H; Izumi S; Hirata H; Kin Y; Kawasaki A; Matsui S; Yokoyama A; Morikage T; Yano S
Tumori; 1991 Aug; 77(4):315-8. PubMed ID: 1746051
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers in the lung cancer diagnosis: a clinical perspective.
Li X; Asmitananda T; Gao L; Gai D; Song Z; Zhang Y; Ren H; Yang T; Chen T; Chen M
Neoplasma; 2012; 59(5):500-7. PubMed ID: 22668014
[TBL] [Abstract][Full Text] [Related]
33. [The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients].
Ni J; Guo Z; Zhang L
Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):25-30. PubMed ID: 26796649
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
Lee JH; Chang JH
Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887
[TBL] [Abstract][Full Text] [Related]
35. The Serum Tumor Markers in Combination for Clinical Diagnosis of Lung Cancer.
Wu H; Wang Q; Liu Q; Zhang Q; Huang Q; Yu Z
Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162867
[TBL] [Abstract][Full Text] [Related]
36. Determination of the best prognostic value of serum tumor markers in patients with suspected lung cancer in an Iranian population.
Sigari N; Mohsenpour B; Nikkhoo B; Ghaderi B; Afkhamzadeh A; Azadi NA; Fathi F; Abdi M
Clin Lab; 2014; 60(1):23-7. PubMed ID: 24600971
[TBL] [Abstract][Full Text] [Related]
37. Early Screening of Colorectal Precancerous Lesions Based on Combined Measurement of Multiple Serum Tumor Markers Using Artificial Neural Network Analysis.
Ke X; Liu W; Shen L; Zhang Y; Liu W; Wang C; Wang X
Biosensors (Basel); 2023 Jun; 13(7):. PubMed ID: 37504084
[TBL] [Abstract][Full Text] [Related]
38. Identification of lung cancer with high sensitivity and specificity by blood testing.
Leidinger P; Keller A; Heisel S; Ludwig N; Rheinheimer S; Klein V; Andres C; Staratschek-Jox A; Wolf J; Stoelben E; Stephan B; Stehle I; Hamacher J; Huwer H; Lenhof HP; Meese E
Respir Res; 2010 Feb; 11(1):18. PubMed ID: 20146812
[TBL] [Abstract][Full Text] [Related]
39. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
[TBL] [Abstract][Full Text] [Related]
40. Computerized analysis of the likelihood of malignancy in solitary pulmonary nodules with use of artificial neural networks.
Nakamura K; Yoshida H; Engelmann R; MacMahon H; Katsuragawa S; Ishida T; Ashizawa K; Doi K
Radiology; 2000 Mar; 214(3):823-30. PubMed ID: 10715052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
